Early diagnosis is critical to improving prognosis. Diagnosis of the disease requires a combination of clinical performance, imaging, laboratory testing and pathological activation. The platform can assist in matching teams of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs.
Treatment and management of early termination requires individual development of treatment programs, typically including drug therapy, rehabilitation interventions, regular follow-up and multidimensional management. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many autoimmune and rheumatic immune disorders that were previously difficult to treat have been significantly improved. Treatment needs to be closely monitored for efficacy and adverse reactions, adapted to timely regimens according to changes in conditions.
Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of premature stroke. The platform serves China International Medical Service System, a team of authoritative experts at home and abroad in the field of autoimmune and rheumatic immunity, to provide the following services to patients: 1. 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.